Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease
Kevin D. Deane, V. Michael Holers, Paul Emery, Kulveer Mankia, Hani El‐Gabalawy, Jeffrey A. Sparks, Karen H. Costenbader, Georg Schett, Annette H M van der Helm–van Mil, Dirkjan van Schaardenburg, Ranjeny Thomas, Andrew P. Cope
Topics & Concepts
MedicineAbataceptRheumatoid arthritisClinical trialPopulationSubclinical infectionDiseaseTocilizumabRituximabIntensive care medicineInternal medicinePhysical therapyImmunologyEnvironmental healthLymphomaRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchAutoimmune and Inflammatory Disorders Research